Novo Nordisk Role & Responsibilities: Novo Nordisk has been at the forefront with its GLP-1 drugs, such as semaglutide (Wegovy), demonstrating substantial weight loss efficacy
For detailed information on peptide shelf life, see the peptide storage guide and peptide expiration article
These symptoms should improve with continued use, not worsen indefinitely
He acknowledges his contribution to the field but stressed the discovery of these medications was done as a community
Heise T, Mari A, DeVries JH et al (2022) Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial